Quadrature Capital »

Sab Biotherapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $135k 35k 3.83

More positions owned by Quadrature Capital

Asml Hldg Nv N Y Registry Shs (ASML)
UnitedHealth (UNH)
Spdr Gold Tr Gold Shs (GLD)
Sap Se Spon Adr (SAP)
Micron Technology (MU)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Circle Internet Group Com Cl A (CRCL)
Crowdstrike Hldgs Cl A (CRWD)
Intel Corporation (INTC)
Toronto Dominion Bk Ont Com New (TD)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Quadrature Capital

Top funds holding Sab Biotherapeutics

Vivo Capital
Caligan Partners
Perceptive Advisors
Commodore Capital
RA Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Millennium Management
Woodline Partners
Vanguard Capital Management
Sessa Capital IM
Boothbay Fund Management
Ameriprise Financial
Ensign Peak Advisors
Soleus Capital Management

View all funds holding Sab Biotherapeutics